Michael Schuster is a renowned hematologic cancer expert who has been the principal investigator for more than 200 clinical trials over the past 20 years and has worked extensively in the area of bone marrow transplantation, cytokines, hematologic malignancies, oncology, new drug development and cachexia. His research interests include improving stem cell transplant outcomes, new drug development in hematologic malignancies, lymphoma and leukemia, therapeutic uses of cytokines and immunotherapy, novel conditioning regimens in bone marrow, and blood stem cell transplantation, as well as the role of pro-inflammatory cytokines in geriatric and cancer cachexia, anemia, and in other disease states.